Skip to main content

Incyte net income

  • INCY · Nasdaq
  • Biotechnology
  • S&P 500
$120.97−0.60%Close 13 Nov 2026 · Market value $24.66B

Incyte's net income was $1.29 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 3845% from fiscal 2024.

In the third quarter of fiscal 2026 (the three months to 30 Sep 2026) it was −$785 million.

Over the four quarters to 30 Sep 2026, net income was $403 million.

From Incyte's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 29 Oct 2026.

Fiscal 2025
$1.29B
+3845%
Q3 FY2026
−$785M
Growth over 9 years
+32.2%
a year, FY 2016–FY 2025

Net income by fiscal year

$104MFY 2016−$313MFY 2017$109MFY 2018$447MFY 2019+308%−$296MFY 2020$949MFY 2021$341MFY 2022−64.1%$598MFY 2023+75.4%$32.6MFY 2024−94.5%$1.29BFY 2025+3845%

Change on the year before, under each year. From FY 2016 to FY 2025, Incyte's net income went from $104 million to $1.29 billion, a compound annual change of +32.2%; FY 2025 is the highest of the period.

Incyte net income, fiscal years
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Net income$104M−$313M$109M$447M−$296M$949M$341M$598M$32.6M$1.29B
Period end31 Dec 201631 Dec 201731 Dec 201831 Dec 201931 Dec 202031 Dec 202131 Dec 202231 Dec 202331 Dec 202431 Dec 2025

Net income by quarter

The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.

Incyte net income, fiscal quarters
PeriodQ4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Net income$201M$158M$405M$424M$299M$303M$586M−$785M
Period end31 Dec 202431 Mar 202530 Jun 202530 Sep 202531 Dec 202531 Mar 202630 Jun 202630 Sep 2026

How net income is measured

Net income is the profit left after every expense, interest and income tax, attributable to the company's shareholders. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.

Incyte's other figures

Net income of comparable companies

Everything on INCY, in the terminal.

Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.